Ginkgo Bioworks Holdings, Inc. (DNA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Ginkgo Bioworks Holdings, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.47x | -0.93x | -3.67x | -1.35x | -5.99x | -101.20x |
| P/B Ratio | 0.91x | 0.71x | 2.99x | 1.63x | 7.28x | 27.77x |
| P/S Ratio | 2.71x | 2.24x | 13.05x | 5.93x | 34.90x | 167.14x |
| Profitability | ||||||
| Gross Margin | 81.5% | 83.0% | 78.5% | 57.3% | 58.7% | 79.6% |
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | -582.6% | -178.8% |
| Net Margin | -183.8% | -240.9% | -355.1% | -440.6% | -583.1% | -165.2% |
| EBITDA Margin | -149.6% | -213.3% | -326.6% | -431.2% | -575.7% | -141.7% |
| Liquidity | ||||||
| Current Ratio | 4.92x | 5.62x | 6.11x | 8.38x | 12.79x | 5.83x |
| Quick Ratio | 4.92x | 5.62x | 6.11x | 8.36x | 12.76x | 5.70x |
| Leverage | ||||||
| Debt/Equity | 0.82x | 0.65x | 0.22x | 0.25x | 0.02x | 0.04x |
YoY = year-over-year change. Source: FMP..